At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitional year in 2023. “We committed to return to growth in 2024 and this is materialising already,” said Belén Garijo, CEO and chair (pictured).